Proprietary E7 antibody-based immunocytochemistry assay for cervical intraepithelial neoplasia detection. Enables immunochemical staining and identification of tissue samples using monoclonal antibody markers. Designed for cervical screening and tissue characterization.
Manufactured by
Attogen Biomedical(Suzhou)Ltd.Inc
China
Attogen Biomedical (Suzhou) Ltd. is a National High-tech Enterprise focused on women's health diagnostics. The company developed China's first cervical cancer-specific protein biomarker detection kits, AI-powered automated medical detection equipment, and related diagnostic software. Founded by Dr. Chang Xiaojia, trained under Nobel laureates at Rockefeller University. ISO13485 certified with over 30 patents.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GenDx Biotech Co., Ltd.
China · 3 relevant products
Qassay
United States · 2 relevant products
Atila BioSystems
United States · 1 relevant product
51 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →11 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 71 closest product alternatives
GenDx Biotech Co., Ltd. · China
Molecular diagnostic assay for HPV genotyping based on E6/E7 gene detection. Identifies human papillomavirus types associated with cervical cancer risk.
GenDx Biotech Co., Ltd. · China
Extended HPV genotyping assay with enhanced detection of E6/E7 markers. Provides comprehensive HPV type identification for cervical cancer screening.
Qassay · United States
Assay for detecting and quantifying cancer-related biomarkers. Supports early detection and monitoring through rapid point-of-care testing.
68 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products